Secondary Prophylaxis in Non-Hodgkin Lymphoma (NHL) and Chemotherapy-induced Thrombocytopenia (ProRom)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2012 by IRCCS San Raffaele.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Amgen
Information provided by (Responsible Party):
Andres J. M. Ferreri, IRCCS San Raffaele
ClinicalTrials.gov Identifier:
NCT01516619
First received: January 8, 2012
Last updated: January 24, 2012
Last verified: January 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2014
  Estimated Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)